Anesthesia and Respiratory Devices

Signal: Philips knew about ventilator defects for years before recall

Multinational electronics and medical device manufacturer Philips knew for over a decade about the defects in its respiratory devices before…

Inspira to unveil new INSPIRA ART medical devices

Inspira Technologies is set to unveil its new INSPIRA ART line of medical devices at the Extracorporeal Life Support Organisation…

Brainomix and TIPAL partner to assess e-Lung platform

Brainomix is set to partner with the TIPAL trial group to assess its e-Lung platform, an artificial intelligence-powered image processing…

Broncus Medical launches new transbronchial needle

Broncus Medical has introduced the new BioStar Transbronchial Aspiration Needle (TBNA) for minimally invasive diagnostic applications. Medical professionals can use…

alveofit receives FDA approval for portable digital spirometer

alveofit (Roundworks Technologies) has received approval from the US Food and Drug Administration (FDA) for its portable digital spirometer, alveoair.…

FDA approves Paragonix’s next-generation donor lung preservation system

The US Food and Drug Administration (FDA) has granted approval for Paragonix Technologies’ next-generation donor lung preservation system, BAROguard. The…

Telesair’s High Flow Oxygen Therapy system receives CE Mark

US-based Telesair has secured the CE Mark for its Bonhawa High Flow Oxygen Therapy system to treat patients with respiratory…

Philips recalls ripple in the respiratory market

A massive voluntary recall of Philips Respironics CPAP and BiPAP devices for sleep apnoea in June 2021 is still having…

Inspira concludes study of blood circulation medical device

Inspira Technologies has concluded a Usability Study for its INSPIRA ART100 blood circulation medical device in Boston, Massachusetts, US. The…

Australian Government grants funding for lung disease scanner development

The Australian Government has granted A$1.1m ($740,000) to 4D Medical for the development of a new lung disease scanner. As…